Discovery Through Partnership: Excellence Through Quality

Products

Product Name
HIF2 alpha Antibody
Catalog #
SMC-185D
Package size
100ug
Price
$255.00 USD
Bulk Quote
Alternate Product Sizes
SMC-185C
Type
Monoclonal
Conjugate
N/A
Datasheet
SMC 185 Hypoxia Inducible Factor 2 Alpha (HIF2Alpha) Cell Signaling
Description
Anti-HIF2 alpha
Research Area
Cell Signaling, Oxidative Stress
Alternative Names
ECYT4, EPAS1, HIF2alpha, HIF1 Alpha like factor, HLF, Hypoxia inducible factor 2 alpha, MOP2, PASD2
Clone Number
EP190B
Host Species
Mouse
Isotype
IgG1
Immunogen
GST-human EPAS-1 (HIF2alpha) amino acids 535-631 fusion protein
Applications
ELISA, WB, IHC, ICC, IF
Species Reactivity
Human
Accession Number
NP_001421.4
Gene ID
2034
SwissProt
Q99814
Background Info
Does not cross react with HIF1Alpha
Recommended Dilutions
1:100-1:500 (WB)
Form
Protein G Purified
Storage Buffer
PBS pH7.4, 50% glycerol, 0.09% sodium azide
Concentration
1mg/mL
Certificate of Analysis
1 μg/mL of SMC-185 was sufficient for detection of HIF2α in 20μg of CoCl2-induced Hela cell lysate by colorimetric immunoblot analysis using Goat anti-mouse IgG:HRP as the secondary antibody.
Storage Temp
-20°C
Shipping Temp
Blue Ice or 4°C

This antibody is available conjugated to several dyes. Please select one of the conjugates from the lists below:

ATTO Conjugates:

ATTO-Conjugates.pdf

Enzyme & Fluorescent Conjugates:

Enzyme-Fluorescent-Conjugate.pdf

IHC analysis of HIF2Alpha using mouse backskin sections.
Courtesy of Dr. Turksen, Ottawa Hospital Research Institute.


Western blot analysis of HIF2 Alpha in CoCl treated HeLa lysates, using a 1:1000 dilution of SMC-185.
Research Background
Members of the hypoxia-inducible factor (HIF) family of transcription factors regulate the cellular response to hypoxia (1). HIF2-Alpha is involved in catecholamine homeostasis, vascular remodeling, physiological angiogenesis and adipogenesis. It is overexpressed in many cancerous tissues, but its exact role in tumour progression remains to be clarified (2). Studies suggest that in the case of non-small cell lung cancer, HIF2-Alpha actually is a promoter of tumor growth and progression in a solid tumor (1). Other data suggests that HIF2-Alpha is an important regulator of innate immunity, and therefore may be useful in the therapeutic target for treating inflammatory disorders and cancer (3).
References
1. Kim W.Y., et al. (2009) J Clin Invest. 119(8): 2160-2170.
2. Favier J., Lapointe S., Maliba R. and Sirois M.G. (2007) BMC Cancer. 7:139.
3. Imtiyaz H.Z., et al. (2010) J Clin Invest. 120(8): 2699-2714.
Cited References
1. Kuan-Ting Lin, Jin-Cherng Lien, Ching-Hu Chung, Sheng-Chu Kuo and Tur-Fu Huang. Bp5250 inhibits vascular endothelial growth factor-induced angiogenesis and HIF-1α expression on endothelial cells. Naunyn-Schmiedeberg's Archives of Pharmacology. doi: 10.1007/s00210-011-0690-2
Order a Print Catalog
*
*
*
*
*
 
*
 
*
*
*
*